CD274 and non-small cell lung carcinoma: Supporting an enhanced ability of EMT-shifted tumor phenotypes to better resist immune cytotoxic cells, correlated expression of PD-L1 expression and EMT markers has been evidenced in tumors and CTCs, particularly in NSCLC (non-small cell lung cancer) and TNBC [130,280,282,283,284,285,286,287].